Xiaowei Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 13
- Ubiquitin and proteasome pathways 10
- RNA Research and Splicing 5
- Chromatin Remodeling and Cancer 4
-
- Cancer-related molecular mechanisms research 12
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Zhihua Liu (23 shared papers)Qingyu Luo (16 shared papers)Pengfei Zhao (12 shared papers)Wan Chang (11 shared papers)Ziyi Fu (9 shared papers)Yabing Nan (9 shared papers)Hui Xie (8 shared papers)Yangyang Cui (6 shared papers)
- Journals
- Cell Reports (4 papers)Cancer Letters (4 papers)Cell Death and Disease (4 papers)Journal of Cellular Physiology (2 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaowei Wu
75 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 547
- Molecular Biology 1.3k
- Oncology 263
- Pathology and Forensic Medicine 171
- Biochemistry 64
Countries citing papers authored by Xiaowei Wu
This map shows the geographic impact of Xiaowei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Wu more than expected).
Fields of papers citing papers by Xiaowei Wu
This network shows the impact of papers produced by Xiaowei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Wu. The network helps show where Xiaowei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 99 | |
| 2 | 2018 | 81 | |
| 3 | 2016 | 80 | |
| 4 | 2017 | 73 | |
| 5 | 2019 | 65 | |
| 6 | 2022 | 64 | |
| 7 | 2020 | 59 | |
| 8 | 2017 | 57 | |
| 9 | 2021 | 55 | |
| 10 | 2019 | 54 | |
| 11 | 2010 | 54 | |
| 12 | 1994 | 53 | |
| 13 | 2017 | 50 | |
| 14 | 2024 | 48 | |
| 15 | 2019 | 46 | |
| 16 | 2015 | 45 | |
| 17 | 2021 | 45 | |
| 18 | 2020 | 40 | |
| 19 | 2016 | 39 | |
| 20 | MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3. | 2016 | 38 |
About Xiaowei Wu
Xiaowei Wu is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Pathology and Forensic Medicine, having authored 79 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (12 papers), Ubiquitin and proteasome pathways (10 papers), Cancer-related Molecular Pathways (7 papers), RNA Research and Splicing (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Mechanisms and Therapy (4 papers) and Chromatin Remodeling and Cancer (4 papers). The work is most often cited by research in Cancer Research (547 citations), Molecular Biology (1.3k citations), Oncology (263 citations), Pathology and Forensic Medicine (171 citations) and Biochemistry (64 citations). Xiaowei Wu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zhihua Liu, Qingyu Luo, Pengfei Zhao, Wan Chang, Ziyi Fu, Yabing Nan, Hui Xie, Yangyang Cui, Yue Huang and Tong Shu. Their work appears in journals such as Cell Reports, Cancer Letters, Cell Death and Disease, Journal of Cellular Physiology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.